Donglin Yang

2.1k total citations
87 papers, 527 citations indexed

About

Donglin Yang is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Donglin Yang has authored 87 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 18 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Donglin Yang's work include Hematopoietic Stem Cell Transplantation (46 papers), Acute Myeloid Leukemia Research (32 papers) and Acute Lymphoblastic Leukemia research (16 papers). Donglin Yang is often cited by papers focused on Hematopoietic Stem Cell Transplantation (46 papers), Acute Myeloid Leukemia Research (32 papers) and Acute Lymphoblastic Leukemia research (16 papers). Donglin Yang collaborates with scholars based in China, United States and Australia. Donglin Yang's co-authors include Erlie Jiang, Jialin Wei, Jing Feng, Jie Cao, Jie Huang, Mingfeng Zhao, Yi He, Sizhou Feng, Weihua Zhai and Qiaoling Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Donglin Yang

69 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donglin Yang China 12 202 137 124 102 70 87 527
Jan Vydra Czechia 10 110 0.5× 87 0.6× 132 1.1× 89 0.9× 123 1.8× 45 454
France Debaugnies Belgium 11 252 1.2× 71 0.5× 23 0.2× 57 0.6× 155 2.2× 19 488
Sophie Ducastelle-Leprêtre France 9 82 0.4× 184 1.3× 198 1.6× 38 0.4× 108 1.5× 27 419
Οlga Benopoulou Greece 8 32 0.2× 83 0.6× 121 1.0× 83 0.8× 54 0.8× 16 394
Marisa Calabuig Spain 12 85 0.4× 338 2.5× 77 0.6× 122 1.2× 112 1.6× 27 613
Carolyn D. Kramer United States 10 55 0.3× 60 0.4× 38 0.3× 198 1.9× 51 0.7× 16 528
Suzanne Cole United States 11 184 0.9× 359 2.6× 26 0.2× 103 1.0× 158 2.3× 13 825
Susan E. Burkett United States 8 132 0.7× 122 0.9× 85 0.7× 117 1.1× 343 4.9× 8 789
JY Djeu United States 11 126 0.6× 131 1.0× 104 0.8× 55 0.5× 117 1.7× 19 612

Countries citing papers authored by Donglin Yang

Since Specialization
Citations

This map shows the geographic impact of Donglin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglin Yang more than expected).

Fields of papers citing papers by Donglin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglin Yang. The network helps show where Donglin Yang may publish in the future.

Co-authorship network of co-authors of Donglin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Donglin Yang. A scholar is included among the top collaborators of Donglin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglin Yang. Donglin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Wang, Jiali, Xinhui Zheng, Qi Sun, et al.. (2024). Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplantation. 59(12). 1654–1666. 2 indexed citations
6.
Wang, Mingyang, Yawei Zheng, Xiaoyu Zhang, et al.. (2024). WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients. Annals of Hematology. 103(8). 2827–2836. 1 indexed citations
7.
8.
He, Yi, Donglin Yang, Qiaoling Ma, et al.. (2023). Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World. Blood. 142(Supplement 1). 5900–5900.
9.
He, Yi, Donglin Yang, Qiaoling Ma, et al.. (2023). Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B‐ALL in CR1 with no detectable minimal residual disease. British Journal of Haematology. 202(2). 369–378. 3 indexed citations
10.
Zhai, Weihua, Jialin Wei, Qiaoling Ma, et al.. (2023). Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS. Blood. 142(Supplement 1). 4952–4952. 1 indexed citations
11.
Liu, Xin, Weihua Zhai, Fengjiao Wang, et al.. (2023). Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation. European Journal Of Haematology. 110(5). 527–533. 7 indexed citations
12.
Zhai, Weihua, Aiming Pang, Donglin Yang, et al.. (2023). Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia. Blood. 142(Supplement 1). 5893–5893.
13.
Yang, Donglin, Rongli Zhang, Xin Chen, et al.. (2023). The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation. Frontiers in Oncology. 13. 1256043–1256043. 3 indexed citations
14.
15.
16.
Huang, Jie, Erlie Jiang, Donglin Yang, et al.. (2020). <p>Metagenomic Next-Generation Sequencing versus Traditional Pathogen Detection in the Diagnosis of Peripheral Pulmonary Infectious Lesions</p>. Infection and Drug Resistance. Volume 13. 567–576. 122 indexed citations
17.
Liu, Meijing, Cuicui Lyu, Wenyi Lu, et al.. (2020). Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant. Frontiers in Oncology. 10. 573822–573822. 39 indexed citations
18.
Huang, Yong, Mingzhe Han, Donglin Yang, et al.. (2020). Comparative Study of Mizoribine and Mycophenolate Mofetil Combined with a Calcineurin Inhibitor-Based Immunosuppressive Regimen in Patients with Alternative Donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(9). 1663–1669. 9 indexed citations
19.
Wang, Qing, Bo Wu, Donglin Yang, et al.. (2020). Optimal specimen type for accurate diagnosis of infectious peripheral pulmonary lesions by mNGS. BMC Pulmonary Medicine. 20(1). 268–268. 32 indexed citations
20.
Zhao, Qinjun, Hongying Ren, Sizhou Feng, et al.. (2014). Aberrant expression and significance of OCT-4A transcription factor in leukemia cells. Blood Cells Molecules and Diseases. 54(1). 90–96. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Vydra Breakdown of academic impact, for papers by France Debaugnies Breakdown of academic impact, for papers by Sophie Ducastelle-Leprêtre Breakdown of academic impact, for papers by Οlga Benopoulou Breakdown of academic impact, for papers by Marisa Calabuig Breakdown of academic impact, for papers by Carolyn D. Kramer Breakdown of academic impact, for papers by Suzanne Cole Breakdown of academic impact, for papers by Susan E. Burkett Breakdown of academic impact, for papers by JY Djeu
Rankless by CCL
2026